Jonathan Maynard

Sidney Kimmel Cancer Center — United States

Immunology and Microbiology · Life Sciences

10h-index245citations29works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(19), Virus-based gene therapy research(15), Cancer Research and Treatments(9), CAR-T cell therapy research(6), T-cell and B-cell Immunology(4)

Publications29 total

Addition of adenoviral vector targeting of chemotherapy to the MUC-1/ecdCD40L VPPP vector prime protein boost vaccine prolongs survival of mice carrying growing subcutaneous deposits of Lewis lung cancer cells
Gene Therapy·2010· 11 citedOpen Access
Use of Adenoviral Vectors to Target Chemotherapy to Tumor Vascular Endothelial Cells Suppresses Growth of Breast Cancer and Melanoma
Molecular Therapy·2010· 12 citedOpen Access
Vector prime protein boost vaccination in the setting of myeloablative-induced lymphopenia suppresses growth of leukemia and solid tumors
Bone Marrow Transplantation·2009· 1 cited
Targeting of chemotherapy to Tie-2-receptor positive angiogenic endothelial cells of tumor vasculature.
Cancer Research·2009
TAA/ecdCD40L VPP Vaccination Induces Robust Adaptive Immune Response Even in Individuals with Post Transplantation Lymphopenia
Blood·2008· 1 cited
Vector Prime-Protein Boost Vaccine Induces 20 Fold Decrease in the Levels of CD44+CD24−/Low Cancer Stem Cells in Epithelial Neoplasms
Blood·2008
Chemotherapy Targeted to Cancer Tissue Potentiates Antigen-specific Immune Response Induced by Vaccine for In Vivo Antigen Loading and Activation of Dendritic Cells
Molecular Therapy·2008· 7 citedOpen Access
Combination of vaccine with targeted chemotherapy reduced levels of CSC like (CD44<sup>+</sup>CD24<sup>- </sup>hematopoietic lineage negative {LIN<sup>-</sup>}) cells and improves outcome of cancer treatment
Journal of Clinical Oncology·2008
Donor lymphocyte infusions from Ad-sig-TAA/ecdCD40L vector prime-TAA/ecdCD40L protein boost (VPP) vaccinated allodonors decrease tumor cell growth post allograft
Journal of Clinical Oncology·2007
Vaccine for cancer and infectious diseases.
Cancer Research·2007
Endothelin-3 growth factor levels decreased in cervical cancer compared with normal cervical epithelial cells
Human Pathology·2007· 26 cited
Vaccine for Cancer and Infectious Diseases (B194)
The Journal of Immunology·2007
Vaccine for Cancer and Infectious Diseases
The Journal of Immunology·2007
44: Pre-clinical study of the effect of the As-sig-TAA/ecdCD40L vector prime-TAA/ecdCD40L protein boost vaccine in elderly recipients for suppression of recurrent cancer following allografting and donor lymphocyte infusions (DLI)
Biology of Blood and Marrow Transplantation·2007Open Access
Mapping of angiogenic markers for targeting of vectors to tumor vascular endothelial cells
Cancer Gene Therapy·2007· 32 cited
Vector Prime/Protein Boost Vaccine That Overcomes Defects Acquired during Aging and Cancer
The Journal of Immunology·2006· 19 cited
Antitumor immune response induced by i.t. injection of vector-activated dendritic cells and chemotherapy suppresses metastatic breast cancer
Molecular Cancer Therapeutics·2006· 17 cited
Vaccine for prevention of breast cancer
Journal of Clinical Oncology·2006
Tumor-specific therapeutic effect induced by an oncolytic adenoviral vector containing heat shock protein 70 and prodrug activation genes
Gene Therapy·2006· 8 cited
Vector Prime-Protein Boost Vaccine Induces Immune Response Against “Self-Antigens” Associated with Epithelial Neoplasms and Tumor Vascular Endothelial Cells.
Blood·2005
page 1 of 2Next →

Frequent Co-authors

Yucheng Tang(21), Hakan Akbulut(18), Albert Deisseroth(17), A. B. Deisseroth(10), Phyllis‐Jean Linton(5), Lixin Zhang(4), K. Gonca Akbulut(4), Y Liu(3), Line Petersen(3), Lone Kjeld Petersen(3), Dejun Sun(2), Yu-Cheng Tang(2), James A. Koziol(2), Jing Yuan(2), T Ye(2), Xiangming Fang(2), Weiwei Zhang(2), Pingchuan Li(2), Tae Hae Han(2), P Li(2)